Jupiter Asset Management’s Relay Therapeutics RLAY Stock Holding History

Jupiter Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.5M	Buy	+719,576	New	+$10.4M	0.07%	271

Other funds holding RLAY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Jupiter Asset Management's RLAY Position: Q2 2026 in Review

Jupiter Asset Management opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 719,576 shares worth $13.5M. The stake represents 0.07% of the portfolio and ranks #271 among its holdings.

79 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

Jupiter Asset Management held 719,576 shares of Relay Therapeutics worth $13.5M as of Q2 2026.
Relay Therapeutics was a new Jupiter Asset Management position in Q2 2026.
Relay Therapeutics made up 0.07% of Jupiter Asset Management's portfolio in Q2 2026, its #271 holding.
79 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.